Vor Biopharma Inc. (VOR) Institutional Ownership

Ownership Summary

Vor Biopharma Inc. (NASDAQ:VOR) has 34 institutional investors with active 13F positions as of June 2025.

• These investors collectively held 910.5% of Vor Biopharma's outstanding shares in June 2025, down from 968.6% in March 2025.
• Their total shares held in VOR decreased -3.46% from the prior quarter, while the number of investors in Vor Biopharma decreased 52.78% year over year.
• Of these 34 funds, 15 grew their exposure to Vor Biopharma, 10 cut back, and 9 maintained positions.
• Combined, these investors held 57.03Mn shares in VOR for June 2025, down by 2.04Mn shares quarter on quarter, and up 2.01Mn shares year over year.
• TCG Crossover Management, LLC leads ownership in VOR with 5.67Mn shares as of June 30, 2025, equal to 90.57% of outstanding shares.
• Top purchasers of VOR stock for the quarter ending June 2025 included TCG Crossover Management, LLC (5.67Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn), MARSHALL WACE, LLP (1.15Mn), Venrock Adviser, LLC (1.1Mn), State Street Corp (1.03Mn).
• Top sellers of VOR stock for the quarter ending June 2025 included FMR LLC (986.5K), Laurion Capital Management LP (315.82K), CITADEL ADVISORS LLC (285.13K), SPHERA FUNDS MANAGEMENT LTD. (88.5K), Johnson & Johnson (53.73K).
• Business Quant data shows the 10 biggest positions in Vor Biopharma as of June 2025 are held by TCG Crossover Management, LLC (5.67Mn), RA CAPITAL MANAGEMENT, L.P. (5.4Mn), FCPM III SERVICES B.V. (4.12Mn), Venrock Adviser, LLC (3.04Mn), Frazier Life Sciences Management, L.P. (2.54Mn), Caligan Partners LP (1.93Mn), GREAT POINT PARTNERS LLC (1.75Mn), Paradigm Biocapital Advisors LP (1.75Mn), FMR LLC (1.54Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn).